$4.860
-0.127 (-2.61%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LXEO Prediction & Forecast by Similar Chart Analysis
Alphio's LXEO stock price prediction model matches the current Lexeo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.96 (+2.04%). The 1-week path is $5.17 (+6.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Lexeo Therapeutics Inc Stock?
Lexeo Therapeutics Inc is currently not a strong buy due to its ongoing losses and recent insider selling, despite positive FDA news. The current price is $4.86, and the stock has a low RSI of 43.96, indicating potential weakness. Additionally, the company has reported a significant net loss of $25,867,000 in Q2 2026, which raises concerns about its financial health. The main risk is the recent insider selling, which has increased by 271.82% over the last month, suggesting a lack of confidence from those closest to the company.
LXEO stock price ended at $4.86 on Friday, after losing -2.61%
Lexeo Therapeutics Inc (LXEO) last closed at $4.86, losing -2.61%. These facts feed the 1-day and 1-week LXEO price prediction above.
Forecast Drivers
Lexeo Therapeutics Inc (LXEO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LXEO, ranked by similarity.
Seasonality analysis for LXEO
Historically the probability of a positive August return for LXEO is 0.00%. December offers the highest probability of a positive month at 51.16%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LXEO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $4.13 | $5.01 | $5.54 | +3.11% |
| Sep 2026 | $3.86 | $4.25 | $5.08 | -12.49% |
| Oct 2026 | $4.53 | $5.01 | $5.16 | +3.11% |
| Nov 2026 | $4.78 | $4.96 | $5.32 | +1.96% |
| Dec 2026 | $3.70 | $4.02 | $4.36 | -17.23% |
In 2026, Lexeo Therapeutics Inc (LXEO) is projected to range from $3.70 to $5.54.
Lexeo Therapeutics Inc 2026 monthly forecast
In Aug 2026, Lexeo Therapeutics Inc is projected to average $5.01, with a low of $4.13 and high of $5.54.
In Sep 2026, Lexeo Therapeutics Inc is projected to average $4.25, with a low of $3.86 and high of $5.08.
In Oct 2026, Lexeo Therapeutics Inc is projected to average $5.01, with a low of $4.53 and high of $5.16.
In Nov 2026, Lexeo Therapeutics Inc is projected to average $4.96, with a low of $4.78 and high of $5.32.
In Dec 2026, Lexeo Therapeutics Inc is projected to average $4.02, with a low of $3.70 and high of $4.36.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.